SFSIG
VYNT

San Francisco Sentry Investment Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

San Francisco Sentry Investment Group’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1
Closed -$2K – 478
2014
Q3 		$2K Hold
1
– – ﹤0.01% 585
2014
Q2 		$2K Buy
+1
New +$1.9K ﹤0.01% 597

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.45B AUM 5.8% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $233M AUM 21.98% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

San Francisco Sentry Investment Group's VYNT Position: Q4 2014 in Review

San Francisco Sentry Investment Group sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2014, closing a stake of 1 share — an estimated $2K sold.

San Francisco Sentry Investment Group first reported a position in VYNT in Q2 2014 and held it in 2 quarters. The position peaked at $2K in Q3 2014. 31 funds tracked by Wall St. Rank hold VYNT as of Q4 2014.

  • San Francisco Sentry Investment Group reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 1 Vyant Bio, Inc. Common Stock share in Q4 2014, an estimated $2K.
  • San Francisco Sentry Investment Group first reported a position in Vyant Bio, Inc. Common Stock in Q2 2014 and held it in 2 quarters.
  • San Francisco Sentry Investment Group's Vyant Bio, Inc. Common Stock position peaked at $2K in Q3 2014.
  • 31 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2014.

Based on San Francisco Sentry Investment Group's 13F filing for Q4 2014, filed 18 Feb 2015.